Calvert Investment Management’s Usana Health Sciences USNA Stock Holding History

Calvert Investment Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-14,160	Closed	-$789K	–	816
2016 Q2	$789K	Buy	+14,160	New	+$854K	0.03%	399
2014 Q3	–	Sell	-72,544	Closed	-$2.83M	–	601
2014 Q2	$2.83M	Buy	72,544 +2,340	+3%	+$86.8K	0.19%	113
2014 Q1	$2.65M	Buy	70,204 +4,192	+6%	+$146K	0.19%	114
2013 Q4	$2.5M	Buy	66,012 +2,932	+5%	+$112K	0.18%	112
2013 Q3	$2.74M	Buy	63,080 +10,110	+19%	+$406K	0.34%	106
2013 Q2	$1.92M	Buy	+52,970	New	+$1.61M	0.26%	117

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Calvert Investment Management's USNA Position: Q3 2016 in Review

Calvert Investment Management sold out of Usana Health Sciences (USNA) in Q3 2016, closing a stake of 14,160 shares — an estimated $789K sold.

Calvert Investment Management first reported a position in USNA in Q2 2013 and held it in 6 quarters. The position peaked at $2.83M in Q2 2014. 140 funds tracked by Wall St. Rank hold USNA as of Q3 2016.

Calvert Investment Management reported no remaining Usana Health Sciences position as of Q3 2016 after selling out during the quarter.
Calvert Investment Management sold 14,160 Usana Health Sciences shares in Q3 2016, an estimated $789K.
Calvert Investment Management first reported a position in Usana Health Sciences in Q2 2013 and held it in 6 quarters.
Calvert Investment Management's Usana Health Sciences position peaked at $2.83M in Q2 2014.
140 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2016.

Based on Calvert Investment Management's 13F filing for Q3 2016, filed 7 Nov 2016.